Therapei Pharmaceuticals Inc entered the industry of Business Services (Unclassified) in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 561499, which describes it as a Business Services (Unclassified). For further clarification, the SIC classifies this business under the code 7389 and described it as a Business Services (Unclassified). The business provides service to the B2B market.
To acquire more information, please contact John Nestor by calling (858) 967-4235 during business hours. You can also write to the business’ Single Location at 725 Lynwood Drive, Encinitas, California CA 92024. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Therapei Pharmaceuticals Inc |
Representative: | John Nestor |
Place of Business: | 725 Lynwood Drive, Encinitas, CA 92024 |
Contact Number: | (858) 967-4235 |
Type of Service: | Business Services (Unclassified) |
SIC Number: | 7389 |
NAICS Number: | 561499 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2004 |
Income/Year: | $100.000 to $499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Therapei Pharmaceuticals Inc is a company operating from San Diego, California providing professional Business Services (Unclassified) and relevant B2B variables. It was founded in 2004 and registered with the SIC code 7389 as Business Services (Unclassified), and with the NAICS code 561499 as Business Services (Unclassified).
With a current employee count of 1 to 4, Therapei Pharmaceuticals Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative John Nestor at (858) 967-4235 for related queries, or to locate its Single Location using the coordinates 33.061704,-117.271507.
The Single Location can also be found at the street address 725 Lynwood Drive in Encinitas, California 92024 and can be engaged online through the company website at , the company Twitter , and Facebook page .